Reaction SMILES: Br[C:2]1[C:7]([F:8])=[CH:6][C:5]([N:9]2[C:18]3[C:13](=[CH:14][C:15]([S:19]([NH:22][C:23]4[CH:27]=[CH:26][O:25][N:24]=4)(=[O:21])=[O:20])=[CH:16][CH:17]=3)[CH:12]=[CH:11][C:10]2=[O:28])=[C:4]([O:29][CH3:30])[CH:3]=1.[F:31][C:32]([F:43])([F:42])[C:33]1[CH:34]=[C:35](B(O)O)[CH:36]=[CH:37][CH:38]=1.C(=O)([O-])[O-].[K+].[K+]>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[F:8][C:7]1[CH:6]=[C:5]([N:9]2[C:18]3[C:13](=[CH:14][C:15]([S:19]([NH:22][C:23]4[CH:27]=[CH:26][O:25][N:24]=4)(=[O:21])=[O:20])=[CH:16][CH:17]=3)[CH:12]=[CH:11][C:10]2=[O:28])[C:4]([O:29][CH3:30])=[CH:3][C:2]=1[C:37]1[CH:36]=[CH:35][CH:34]=[C:33]([C:32]([F:43])([F:42])[F:31])[CH:38]=1
Reactant: COc1cc(Br)c(F)cc1-n1c(=O)ccc2cc(S(=O)(=O)Nc3ccon3)ccc21
Reactant: OB(O)c1cccc(C(F)(F)F)c1
Agent: c1ccc([P](c2ccccc2)(c2ccccc2)[Pd]([P](c2ccccc2)(c2ccccc2)c2ccccc2)([P](c2ccccc2)(c2ccccc2)c2ccccc2)[P](c2ccccc2)(c2ccccc2)c2ccccc2)cc1
Agent: O=C([O-])[O-]
Agent: [K+]
Product: COc1cc(-c2cccc(C(F)(F)F)c2)c(F)cc1-n1c(=O)ccc2cc(S(=O)(=O)Nc3ccon3)ccc21
Temperature: 90 °C

Procedure:
A flask was charged with 1-(4-bromo-5-fluoro-2-methoxyphenyl)-N-(isoxazol-3-yl)-2-oxo-1,2-dihydroquinoline-6-sulfonamide (257 mg, 0.520 mmol), 3-(trifluoromethyl)benzeneboronic acid (148 mg, 0.780 mmol), potassium carbonate (216 mg, 1.560 mmol), and Pd(Ph3P)4 (60.1 mg, 0.052 mmol). The vial was sealed with a septum cap and flushed with N2 (g), then Dioxane (1.950 mL) and Water (0.650 mL) were added via syringe. The mixture heated at 90° C. for 40 min. HCl (4 mL, 1M aq) was added and the mixture was extracted with EtOAc (2×10 mL). The combined organic layers were concentrated and the resulting residue was absorbed onto a plug of silica gel for purification by silica gel chromatography. The product was eluted through a Redi-Sep pre-packed silica gel column (12 g), eluting with a gradient of 0% to 3% MeOH in CH2Cl2, to provide racemic 1-(2-fluoro-5-methoxy-3′-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)-N-(isoxazol-3-yl)-2-oxo-1,2-dihydroquinoline-6-sulfonamide. Racemic 1-(2-fluoro-5-methoxy-3′-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)-N-(isoxazol-3-yl)-2-oxo-1,2-dihydroquinoline-6-sulfonamide was subjected to chiral separation by SFC on an AS-H column (20% MeOH/80% CO2) to give (P)-1-(2-fluoro-5-methoxy-3′-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)-N-(isoxazol-3-yl)-2-oxo-1,2-dihydroquinoline-6-sulfonamide as peak 1 and (M)-1-(2-fluoro-5-methoxy-3′-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)-N-(isoxazol-3-yl)-2-oxo-1,2-dihydroquinoline-6-sulfonamide as peak 2. Both peaks were isolated as off-white solids. Data for peak 1: 1H NMR (500 MHz, DMSO-d6) δ 11.6 (br s, 1H), 8.72 (d, J=1.71 Hz, 1H), 8.38 (d, J=2.03 Hz, 1H), 8.24 (d, J=9.72 Hz, 1H), 8.01 (br. s., 2H), 7.77-7.90 (m, 3H), 7.56 (d, J=10.31 Hz, 1H), 7.48 (d, J=6.89 Hz, 1H), 6.89 (d, J=8.98 Hz, 1H), 6.82 (d, J=9.67 Hz, 1H), 6.45 (d, J=1.71 Hz, 1H), 3.70-3.80 (s, 3H). m/z (ESI) 558.0 (M−H)−. Data for peak 2: 1H NMR (500 MHz, DMSO-d6) δ 11.66 (br. s., 1H), 8.72 (d, J=1.71 Hz, 1H), 8.38 (d, J=2.03 Hz, 1H), 8.24 (d, J=9.67 Hz, 1H), 8.01 (br. s., 2H), 7.76-7.90 (m, 3H), 7.56 (d, J=10.31 Hz, 1H), 7.48 (d, J=6.89 Hz, 1H), 6.89 (d, J=8.98 Hz, 1H), 6.82 (d, J=9.67 Hz, 1H), 6.45 (d, J=1.71 Hz, 1H), 3.75 (s, 3H). m/z (ESI) 558.0 (M−H)−.